Some observations on the interaction of dopamine-beta-hydroxylase and its natural inhibitors in the rat brain.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 1000363)

Published in Can J Biochem on November 01, 1976

Authors

P H Yu, A A Boulton, P H Wu

Articles citing this

Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J (Clin Res Ed) (1981) 1.11

Articles by these authors

Intestinal inflammatory pseudotumour with regional lymph node involvement: identification of a new bacterium as the aetiological agent. J Pathol (2000) 3.20

Ionic pair complexes with well-separated columnar stack structure based on [Pt(mnt)2]- ions showing unusual magnetic transition: syntheses, crystal structures, and magnetic properties. Inorg Chem (2004) 2.40

The role of adenosine and its nucleotides in central synaptic transmission. Prog Neurobiol (1981) 2.03

2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system? J Neurochem (1990) 1.29

Nutrient release and sediment oxygen demand in a eutrophic land-locked embayment in Hong Kong. Environ Int (2001) 1.23

Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: evaluation of structure-activity relationships. Life Sci (1982) 1.15

Green light stimulates terahertz emission from mesocrystal microspheres. Nat Nanotechnol (2011) 1.08

Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors. J Med Chem (1992) 1.06

Proteolytic enzymes of Neurospora crassa. Purification and some properties of five intracellular proteinases. Eur J Biochem (1975) 1.03

Adenosine receptor agonists inhibit K+-evoked Ca2+ uptake by rat brain cortical synaptosomes. J Neurochem (1982) 1.03

Neurorescuing effects of the GAPDH ligand CGP 3466B. J Neural Transm Suppl (2000) 1.02

Identification and distribution of m-tyramine in the rat. Can J Biochem (1975) 1.02

Benzodiazepines inhibit adenosine uptake into rat brain synaptosomes. Brain Res (1980) 1.02

Identification and distribution of benzylamine in tissue extracts isolated from rats pretreated with pargyline. Biochem Pharmacol (1976) 1.01

Identification and distribution of p-tyramine in the rat. Can J Biochem (1974) 1.01

Separation and quantitation of some urinary arylalkylamines. J Chromatogr (1976) 1.01

Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation. J Neurosci (2001) 1.00

Glyceraldehyde-3-phosphate dehydrogenase and apoptosis. J Neurosci Res (2000) 1.00

Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat. Neurosci Lett (1984) 0.99

Studies on the apparent instability of Neurospora tryptophan synthase. Evidence for protease. Eur J Biochem (1973) 0.98

Specific binding of 2-[3H]chloroadenosine to rat brain cortical membranes. Can J Physiol Pharmacol (1980) 0.97

Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.97

Inapparent infection of hepatitis A virus. Am J Epidemiol (1988) 0.97

Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain. J Neurochem (1992) 0.96

Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol (1997) 0.96

Irreversible inhibition of monoamine oxidase by some components of cigarette smoke. Life Sci (1987) 0.96

Some arylalkylamines in rabbit brain. Brain Res (1975) 0.95

Actions of arachidonic acid and hepoxilin A3 on mammalian hippocampal CA1 neurons. Brain Res (1989) 0.95

Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins. J Neurosci Res (1999) 0.94

The subcellular distribution of beta-phenylethylamine, p-tyramine and tryptamine in rat brain. J Neurochem (1975) 0.94

Gene expression of aromatic L-amino acid decarboxylase in cultured rat glial cells. J Neurochem (1992) 0.94

Synaptic GABAergic and glutamatergic mechanisms underlying alcohol sensitivity in mouse hippocampal neurons. J Physiol (2006) 0.94

Identification and distribution of beta-phenylethylamine in the rat. Can J Biochem (1973) 0.93

Gradation of kainic acid-induced rat limbic seizures and expression of hippocampal heat shock protein-70. Eur J Neurosci (1997) 0.93

Trace amines and mental disorders. Can J Neurol Sci (1980) 0.93

Further studies on the inhibition of adenosine uptake into rat brain synaptosomes by adenosine derivatives and methylxanthines. Gen Pharmacol (1984) 0.93

Distribution and release of adenosine triphosphate in rat brain. Neurochem Res (1978) 0.92

The effects of reserpine and 6-hydroxydopamine on the concentrations of some arylakylamines in rat brain. Br J Pharmacol (1977) 0.92

The automated analysis of absorbent and fluorescent substances separated on paper strips. Methods Biochem Anal (1968) 0.92

Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme. Neurochem Res (1996) 0.91

Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders. Cancer (1999) 0.91

Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J Neurosci (1993) 0.90

The characterization of [3H] adenosine uptake into rat cerebral cortical synaptosomes. J Neurochem (1980) 0.90

Iontophoretic studies of some trace amines in the mammalian CNS. Brain Res (1979) 0.90

Patterns of shedding of hepatitis A virus antigen in feces and of antibody responses in patients with naturally acquired type A hepatitis. J Infect Dis (1980) 0.90

Studies on the pargyline-binding site of different types of monoamine oxidase. Can J Biochem (1981) 0.90

The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum. J Neurochem (1979) 0.90

The identification of NP25: a novel protein that is differentially expressed by neuronal subpopulations. Brain Res Mol Brain Res (1994) 0.89

Biosynthesis and excretion of meta and para tyramine in the rat. Life Sci (1974) 0.89

Up-regulation of brain [3H]diazepam binding sites in chronic caffeine-treated rats. Brain Res (1984) 0.89

The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol C (1982) 0.88

Specific irreversible monoamine oxidase B inhibitors stimulate gene expression of aromatic L-amino acid decarboxylase in PC12 cells. J Neurochem (1992) 0.88

Susceptibility of monkeys to human hepatitis A virus. J Infect Dis (1981) 0.88

In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine. Neurochem Res (1987) 0.87

Distribution, metabolism, and disappearance of intraventricularly injected p-tyramine in the rat. Can J Biochem (1974) 0.87

Overexpression of type 7 adenylyl cyclase in the mouse brain enhances acute and chronic actions of morphine. Mol Pharmacol (2000) 0.86

The trace amines and their acidic metabolites in depression--an overview. Prog Neuropsychopharmacol Biol Psychiatry (1994) 0.86

Separation, detection and quantitative analysis of urinary beta-phenylethylamine. J Chromatogr (1971) 0.85

The effects of acute and chronic administration of beta-phenylethylamine on food intake and body weight in rats. Prog Neuropsychopharmacol (1981) 0.85

Quantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomide. Br J Radiol (2011) 0.85

Catecholamines and the sodium pump in excitable cells. Prog Neurobiol (1981) 0.85

Identity of a urinary "pink spot" in schizophrenia and Parkinson's disease. Nature (1967) 0.85

Possible mechanism of action of deprenyl in parkinsonism. Lancet (1990) 0.85

Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues. Biochem Pharmacol (1986) 0.85

Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells. Psychopharmacology (Berl) (1995) 0.85

Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate. Eur J Pharmacol (1976) 0.84

The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol Appl Neurobiol (2007) 0.84

The rapid uptake and release of [3H]adenosine by rat cerebral cortical synaptosomes. J Neurochem (1981) 0.84

Interactions between p-tyramine, m-tyramine, or beta-phenylethylamine and dopamine on single neurones in the cortex and caudate nucleus of the rat. Can J Physiol Pharmacol (1980) 0.84

Effect of acute and chronic injections of amphetamine on intracranial self-stimulation (ICS) and some aryl alkyl amines and the rat brain. Life Sci (1976) 0.84

Identification, distribution, metabolism, and function of meta and para tyramine, phenylethylamine and tryptamine in brain. Adv Biochem Psychopharmacol (1976) 0.84

Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus. J Neurochem (1994) 0.84

Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors. Eur J Pharmacol (1993) 0.84

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline may be toxic in presence of increased dopamine concentrations. BMJ (1996) 0.83

Ethanol tolerance in hippocampal neurons: adaptive changes in cellular responses to ethanol measured in vitro. J Pharmacol Exp Ther (1990) 0.83

Prolongation of life in an experimental model of aging in Drosophila melanogaster. Neurochem Res (1999) 0.83

Metabolism distribution, and disappearance of injected beta-phenylethylamine in the rat. Can J Biochem (1975) 0.83

The effect of morphine on purine and acetylcholine release from rat cerebral cortex: evidence for a purinergic component in morphine's action. Pharmacol Biochem Behav (1980) 0.83

m-Octopamine, p-octopamine and phenylethanolamine in rat brain: a sensitive, specific assay and the effects of some drugs. J Neurochem (1977) 0.83

An Alu sequence interrupts a human 5-hydroxytryptamine1D receptor pseudogene. Gene (1993) 0.83

Radioenzymatic estimation of S-adenosylmethionine in rat brain regions and subcellular fractions. Anal Biochem (1978) 0.83

Chronic L-deprenyl or L-amphetamine: equal cognitive enhancement, unequal MAO inhibition. Pharmacol Biochem Behav (1994) 0.83

Morphine enhances adenosine release from the in vivo rat cerebral cortex. Eur J Pharmacol (1980) 0.83

A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices. Eur J Pharmacol (1980) 0.83

Effect of L-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake. Neuropharmacology (1994) 0.83

Identification and distribution of tryptamine in the rat. Can J Biochem (1974) 0.83

Evidence for the presence of m-tyramine, p-tyramine, tryptamine, and phenylethylamine in the rat brain and several areas of the human brain. Biol Psychiatry (1978) 0.82

Activation of platelet monoamine oxidase by plasma in the human. Life Sci (1979) 0.82

Effects of yeast proteinase and its inhibitor on the inactivation of tryptophan synthase from Saccharomyces cerevisiae and Neurospora crassa. Eur J Biochem (1973) 0.82

NMDA antagonist inhibits rapid tolerance to ethanol. Brain Res Bull (1991) 0.82

Net production of gamma-aminobutyric acid in astrocytes in primary cultures determined by a sensitive mass spectrometric method. J Neurochem (1979) 0.82